AVLAYAH
NDC 84976-001, tividenofusp alfa-eknm, injection, powder, lyophilized, for solution, from Denali Therapeutics Inc..
- Product NDC
- 84976-001
- Status
- Listed
- Labeler
- Denali Therapeutics Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761485
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/84976-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIVIDENOFUSP ALFA150 mg/5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84976-001-01 | 84976000101 | 1 VIAL in 1 CARTON (84976-001-01) / 5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/014d92c1-b643-4680-8ca6-f0b3307da915
Use it
Look up 84976-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84976-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84976-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.